Research & Development Market Research Reports & Industry Analysis
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
Research & Development Industry Research & Market Reports
-
2025 Biotech Research and Development Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... with forecasts for 2025 and 2029. The historical data utilizes in-depth survey results from companies in the Biotech Research and Development industry combined with country and regional economic, firmographic, and demographic data. Our analysts develop ... Read More
-
Biotech Research and Development - US Industry Market Research Report with Recession Risk Analysis & Forecasts
... Insights report is full of industry insights including historical and forecasted market size, revenue and industry breakdowns by product lines, size of company, concentration segmentation, business structure, customer type, state and MSA, profitability, financial ratios, ... Read More
-
Bio Industry Markets in China
... which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply ... Read More
-
Small Molecule CMO/CDMO Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Biotech Business March 2025
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
Top 6 Growth Opportunities in Pharma-Biotech, 2025
... and drug approvals, as breakthrough treatments, particularly in personalized medicine, promise to revolutionize patient care. Oncology will remain the most valuable therapy area, while the immunomodulator segment will grow through existing blockbuster sales, and obesity ... Read More
-
Global Certified Reference Materials Market - 2023-2030
... quality and metrological traceability of products, validate analytical measurement methods, or calibrate instruments. Certified reference material is a particular form of measurement standard. Reference materials are essential for analytical chemistry and clinical analysis. Since most ... Read More
-
Global Organ-On-Chip Market - 2024 - 2031
... 2024-2031. The organ-on-chip market trends show increasing government initiatives and investment in drug development owing to the rising prevalence of oncology and increasing research and development. Organ-on-chip aims to design human tissue prototypes for disease ... Read More
-
Global Organoids Market - 2024 - 2031
... to replicate much of an organ's complexity or express selected aspects, like producing only certain types of cells. Organoids Market Dynamics and Trends The global organoids market is driven by technological advancements in 3D cell ... Read More
-
Antimicrobial Susceptibility Testing Market, By Product Type (Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, and Consumables), By Application (Antibacterial, Antifungal, Anti-parasitic, and Antiviral), By Method (Disk Diffusion, Rapid Automated AST, Broth Dilution, Gradient Diffusion, and Genotypic Methods), By End User (Hospitals, Pathology/Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... market is projected to witness significant growth from 2025 to 2032. This is mainly due to the rising prevalence of infectious diseases worldwide and increasing need to identify appropriate antibiotic treatments. As per recent studies, ... Read More
-
2025 Biotech Research and Development Global Market Size & Growth Report with Updated Analysis & Forecasts
... with forecasts for 2025 and 2029. The historical data utilizes in-depth survey results from companies in the Biotech Research and Development industry combined with country and regional economic, firmographic, and demographic data. Our analysts develop ... Read More
-
Biohacking Market Size, Share & Trends Analysis Report By Product (Wearables, Implants, Smart Drugs, Gene Modification Kits), By Application (Genetic Engineering, Forensic Science, Synthetic Biology), By End-use, By Region, And Segment Forecasts, 2025 - 2
... at a CAGR of 18.95% from 2025 to 2030. Various initiatives by market players and rising funds for biohacking are the major factors fueling the market growth. The adoption of biohacking practices is growing due ... Read More
-
Cold Plasma
... CAGR of 14.8% over the analysis period 2024-2030. Atmospheric Regime, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$3.7 Billion by the end of the analysis ... Read More
-
Protein Characterization and Identification
... 2030, growing at a CAGR of 13.2% over the analysis period 2024-2030. Protein Characterization & Identification Consumables, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$17.2 ... Read More
-
Bone Marrow Aspirate Concentrates
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Bone Marrow Aspirate Concentrates Systems, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$178.5 ... Read More
-
Asthma Therapeutics
... CAGR of 2.3% over the analysis period 2024-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$10.7 Billion by the end of the analysis ... Read More
-
Bioburden Testing
... CAGR of 11.3% over the analysis period 2024-2030. Bioburden Testing Consumables, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Peptide Synthesis
... CAGR of 4.3% over the analysis period 2024-2030. Peptide Synthesis Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the ... Read More
-
Drug Discovery Technologies
... at a CAGR of 8.7% over the analysis period 2024-2030. Small Molecule Drugs, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$92.7 Billion by the end ... Read More
-
Virus Filtration Products
... at a CAGR of 12.4% over the analysis period 2024-2030. Virus Filtration Kits & Reagents, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$7.8 Billion by ... Read More
-
Recombinant DNA Technology
... at a CAGR of 4.5% over the analysis period 2024-2030. Medical Recombinant DNA Technology, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$77.9 Billion by the ... Read More
-
Research Antibodies
... CAGR of 4.7% over the analysis period 2024-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$5.4 Billion by the end of the analysis period. ... Read More
-
Genomics in Cancer Care
... 2030, growing at a CAGR of 16.7% over the analysis period 2024-2030. Genomics Instruments, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$25.0 Billion by the ... Read More
-
In Vivo Contract Research Organization (CRO)
... reach US$8.0 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Smalll Molecules Modality, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and ... Read More
-
Cancer Immunotherapy
... CAGR of 13.7% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$266.2 Billion by the end of the analysis ... Read More
Research Assistance
